LONG-TERM EFFICACY OF VEMURAFENIB (VEM) + RITUXIMAB (RTX) IN PATIENTS (PTS) WITH RECURRENT/REFRACTORY (R/R) TRICHOLEUKEMIA (HCL) ENROLLED IN THE ACADEMIC PHASE-2 HCL-PG03 TRIAL (SIE 2026) - Oct 6, 2026 - Abstract #C022; Pres time: Sep 21, 2026; 03:40 PM - 05:10 PM; Location: HALL 1; No abstract available
Clinical • P2 data • Hematological Malignancies • Leukemia
|
|
L. De Carolis; M. Capponi; A. Mancini; A. Pucciarini; G.M. D'Elia; E. Lucia; M.P. Martelli; D. Gottardi; R. Moia; F. Zaja; R. Plos; B. Falini; E. Tiacci
|